← Leaderboards
Charles M. Stein
Vanderbilt University
$20,921,975
Attributed
$21,206,985
Total exposure
23
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2005–23$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$28,313,036 · 25
By mechanism
R01$11,467,044 · 5
P60$6,210,663 · 1
T32$5,083,027 · 1
P01$2,933,191 · 3
R35$1,700,000 · 1
K24$692,056 · 1
Top collaborators
- Jens Marc Titze1 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Randy D Blakely$29,330,449
- Annet Kirabo$7,301,987
- Pratik Pandharipande$5,788,307
- Nicholas Andrew Harris$143,899
- Bretton Nabit$94,759
Others in their field
Top investigators on “Inflammation”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$89,523,713
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Randall J Bateman · Washington University$64,707,456
- Peter Scott Heeger · Case Western Reserve University$56,547,884
Research focus
InflammationResponseAffectHuman SubjectCardiovascular SystemGenetic PolymorphismGeneticOxidative StressAtherosclerosisBasic ScienceBlood VesselsMediatingMorbidity - Disease RateTranslatingVariantLinkMortality Vital StatisticsDrug UsageGenesBasePreventClinical ResearchClinical PracticeIn Vitro
Grant awards (83)
Pharmacogenetics to improve drug therapy$340,000
R35 · FY2023 · GM · contact PI
Pharmacogenetics to improve drug therapy$340,000
R35 · FY2022 · GM · contact PI
Salt, Blood Pressure, and Inflammation$561,784
R01 · FY2021 · HL · contact PI
Pharmacogenetics to improve drug therapy$340,000
R35 · FY2021 · GM · contact PI
Salt, Blood Pressure, and Inflammation$561,683
R01 · FY2020 · HL · contact PI
Pharmacogenetics to improve drug therapy$340,000
R35 · FY2020 · GM · contact PI
Salt, Blood Pressure, and Inflammation$561,584
R01 · FY2019 · HL · contact PI
Pharmacogenetics to improve drug therapy$340,000
R35 · FY2019 · GM · contact PI
Clinical Pharmacology Training Program$625,837
T32 · FY2018 · GM · contact PI
Salt, Blood Pressure, and Inflammation$570,020
R01 · FY2018 · HL · contact PI
Drug Metabolism Genotypes in Clinical Practice$284,400
R01 · FY2018 · GM · contact PI
Clinical Pharmacology Training Program$607,490
T32 · FY2017 · GM · contact PI
Clinical Effects of Genetic Variability In Adrenergic Receptors$310,276
P01 · FY2016 · HL · contact PI
Clinical Pharmacology Training Program$307,792
T32 · FY2016 · GM · contact PI
Drug Metabolism Genotypes in Clinical Practice$284,400
R01 · FY2016 · GM · contact PI
Clinical Pharmacology Training Program$360,059
T32 · FY2015 · GM · contact PI
Clinical Effects of Genetic Variability In Adrenergic Receptors$292,639
P01 · FY2015 · HL · contact PI
Drug Metabolism Genotypes in Clinical Practice$282,600
R01 · FY2015 · GM · contact PI
Clinical Pharmacology Training Program$203,629
T32 · FY2015 · GM · contact PI
Clinical Pharmacology Training Program$425,435
T32 · FY2014 · GM · contact PI
Clinical Effects of Genetic Variability In Adrenergic Receptors$325,796
P01 · FY2014 · HL · contact PI
Drug Metabolism Genotypes in Clinical Practice$281,700
R01 · FY2014 · GM · contact PI
Clinical Pharmacology Training Program$488,331
T32 · FY2013 · GM · contact PI
Clinical Effects of Genetic Variability In Adrenergic Receptors$264,974
P01 · FY2013 · HL · contact PI
Vanderbilt Multidisciplinary Clinical Research Center$1,228,000
P60 · FY2012 · AR · contact PI
Clinical Pharmacology Training Program$486,960
T32 · FY2012 · GM · contact PI
Clinical Effects of Genetic Variability In Adrenergic Receptors$303,030
P01 · FY2012 · HL · contact PI
Clinical Pharmacology Training Program$61,830
T32 · FY2012 · GM · contact PI
Vanderbilt Multidisciplinary Clinical Research Center$1,283,267
P60 · FY2011 · AR · contact PI
Fish Oil for Atrial Fibrillation-Effect and Mechanisms$723,919
R01 · FY2011 · HL · contact PI
Clinical Pharmacology Training Program$301,178
T32 · FY2011 · GM · contact PI
PRESYNAPTIC CHOLINE TRANSPORTERS IN THE HEART$270,544
P01 · FY2011 · HL · contact PI
Vanderbilt Multidisciplinary Clinical Research Center$1,239,950
P60 · FY2010 · AR · contact PI
Fish Oil for Atrial Fibrillation-Effect and Mechanisms$731,233
R01 · FY2010 · HL · contact PI
Clinical Pharmacology Training Program$456,393
T32 · FY2010 · GM · contact PI
Vascular Damage in SLE$335,359
R01 · FY2010 · HL · contact PI
PRESYNAPTIC CHOLINE TRANSPORTERS IN THE HEART$270,544
P01 · FY2010 · HL · contact PI
Vanderbilt Multidisciplinary Clinical Research Center$1,239,954
P60 · FY2009 · AR · contact PI
Fish Oil for Atrial Fibrillation-Effect and Mechanisms$748,463
R01 · FY2009 · HL · contact PI
Clinical Pharmacology Training Program$445,921
T32 · FY2009 · GM · contact PI
Vascular Damage in SLE$335,359
R01 · FY2009 · HL · contact PI
Vanderbilt Multidisciplinary Clinical Research Center$1,219,492
P60 · FY2008 · AR · contact PI
Fish Oil for Atrial Fibrillation-Effect and Mechanisms$745,563
R01 · FY2008 · HL · contact PI
Vascular Damage in SLE$335,359
R01 · FY2008 · HL · contact PI
Clinical Pharmacology Training Program$312,172
T32 · FY2008 · GM · contact PI
ASPIRIN RESISTANCE IN RHEUMATIC DISEASES$1,441
M01 · FY2008 · RR · contact PI
PHYSIOLOGY AND PHARMACOLOGY OF A-ADRENERGIC RECEPTOR VARIABILITY$609
M01 · FY2008 · RR · contact PI
VASCULAR DAMAGE IN SLE$70
M01 · FY2008 · RR · contact PI
Fish Oil for Atrial Fibrillation-Effect and Mechanisms$755,164
R01 · FY2007 · HL · contact PI
Vascular Damage in SLE$331,437
R01 · FY2007 · HL · contact PI
Regulation of Human Vascular Response$94,397
K24 · FY2007 · HL · contact PI
ASPIRIN RESISTANCE IN RHEUMATIC DISEASES$30,582
M01 · FY2007 · RR · contact PI
PHYSIOLOGY AND PHARMACOLOGY OF A-ADRENERGIC RECEPTOR VARIABILITY$12,929
M01 · FY2007 · RR · contact PI
VASCULAR DAMAGE IN SLE$1,491
M01 · FY2007 · RR · contact PI
DETERMINANTS OF INDIVIDUAL RESPONSIVENESS TO DRUGS$895,388
P01 · FY2006 · GM · contact PI
Vascular Damage in SLE$340,423
R01 · FY2006 · HL · contact PI
Regulation of Human Vascular Response$91,648
K24 · FY2006 · HL · contact PI
ATHEROSCLEROSIS IN RA$21,812
M01 · FY2006 · RR · contact PI
ASPIRIN RESISTANCE IN RHEUMATIC DISEASES$10,486
M01 · FY2006 · RR · contact PI
VASCULAR DAMAGE IN SLE$2,098
M01 · FY2006 · RR · contact PI
Regulation of Human Vascular Response$88,979
K24 · FY2005 · HL
ATHEROSCLEROSIS IN RA$43,751
M01 · FY2005 · RR
VASCULAR DAMAGE IN SLE$11,513
M01 · FY2005 · RR
ATHEROSCLEROSIS IN RA$339,750
R01 · FY2004 · HL
VASCULAR DAMAGE IN SLE$339,750
R01 · FY2004 · HL
Regulation of Human Vascular Response$86,387
K24 · FY2004 · HL
Atherosclerosis in RA$61,621
M01 · FY2004 · RR
Vascular Damage In SLE$28,060
M01 · FY2004 · RR
VASCULAR DAMAGE IN SLE$339,750
R01 · FY2003 · HL
ATHEROSCLEROSIS IN RA$339,750
R01 · FY2003 · HL
REGULATION OF HUMAN VASCULAR RESPONSE$85,977
K24 · FY2003 · HL
ATHEROSCLEROSIS IN RA$336,337
R01 · FY2002 · HL
VASCULAR DAMAGE IN SLE$334,951
R01 · FY2002 · HL
REGULATION OF HUMAN VASCULAR RESPONSE$83,709
K24 · FY2002 · HL
GENETIC VARIABILITY &VASCULAR RESPONSE$0
M01 · FY2002 · RR
ATHEROSCLEROSIS IN RA$333,153
R01 · FY2001 · HL
VASCULAR DAMAGE IN SLE$333,153
R01 · FY2001 · HL
REGULATION OF HUMAN VASCULAR RESPONSE$81,528
K24 · FY2001 · HL
GENETIC VARIABILITY &VASCULAR RESPONSE$0
M01 · FY2001 · RR
GENETIC VARIABILITY &VASCULAR RESPONSE$0
M01 · FY2001 · RR
GENETIC VARIABILITY &VASCULAR RESPONSE$0
M01 · FY2001 · RR
REGULATION OF HUMAN VASCULAR RESPONSE$79,431
K24 · FY2000 · HL
GENETIC VARIABILITY &VASCULAR RESPONSE$592
M01 · FY2000 · RR